Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-018903

Chief Executive Officer sold 5,675 shares at $217.39 ($1,233,716)

  • Chief Executive Officer acquired 5,675 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2023-06-15 Option exercise 10b5-1 +5,675 $57.76 $327,788 442,605 D
Farrell Michael J. Chief Executive Officer 2023-06-15 Sale 10b5-1 −5,675 $217.39 $1,233,716 436,930 D
Derivatives
Farrell Michael J. Chief Executive Officer 2023-06-15 Option exercise · ResMed Common Stock Options 10b5-1 −5,675 31,840 D
Open-market sales · 5,675 sh · avg $217.39 · $1,233,716
Loading xslF345X04/form4.xml…